Viavi Solutions
VIAV
46.27
-1.87
-3.88%
Viavi Solutions
US · VIAV
#1351 by market cap
Listed 2015
46.27
-1.87
-3.88%
Live - 5344 symbols - heartbeat 362s ago
· 2026-10-08 07:00
Pre-market
45.51
-1.65%
After-hours
46.40
+0.28%
Overnight
45.54
-1.58%
- Market cap
- 11.38B
- P/E (TTM)i
- -355.92
- P/Bi
- 7.86
- EPSi
- -0.13
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on VIAV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -29.66, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +40.03% YoY
Margins
- Gross margin
- 57.66%
- Operating margin
- 7.97%
- Net margin
- -2.00%
Key ratios & quality
- Enterprise valuei
- 11.38B
- Altman Z-Scorei
- -29.66
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13B | 1.14B | 1.20B | 1.29B | 1.11B | 1.00B | 1.08B | 1.52B |
| Gross profit | 651.40M | 665.30M | 714.40M | 773.50M | 638.80M | 575.90M | 621.10M | 875.40M |
| Selling & admin expenses | 343.50M | 315.00M | 337.50M | 365.70M | 328.70M | 333.30M | 349.40M | 469.20M |
| Research & development | 187.00M | 193.60M | 203.00M | 213.20M | 206.90M | 201.90M | 208.70M | 262.70M |
| Operating profit | 82.80M | 121.60M | 140.60M | 184.90M | 94.50M | 34.40M | 58.20M | 121.00M |
| Pretax profit | 39.30M | 114.30M | 130.80M | 65.10M | 60.70M | 11.60M | 38.60M | 16.30M |
| Tax | 31.50M | 65.30M | 63.30M | 49.60M | 35.20M | 37.40M | 4.40M | 47.50M |
| Net profit | 5.40M | 49.00M | 67.50M | 15.50M | 25.50M | -25.80M | 34.80M | -30.40M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.02 | 0.21 | 0.29 | 0.07 | 0.11 | -0.12 | 0.15 | -0.13 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 284.80M | 290.50M | 299.10M | 369.30M | 406.80M | 443.10M |
| Gross profit | 160.70M | 163.50M | 169.00M | 210.60M | 234.10M | 261.70M |
| Selling & admin expenses | 101.30M | 89.70M | 104.20M | 127.10M | 113.60M | 124.30M |
| Research & development | 50.00M | 57.20M | 56.00M | 65.90M | 71.00M | 69.80M |
| Operating profit | 8.20M | 15.10M | 7.30M | 11.30M | 42.10M | 60.30M |
| Pretax profit | 3.20M | 9.60M | -2.30M | -38.70M | 13.80M | 43.50M |
| Tax | -16.30M | 2.20M | 19.00M | 9.70M | 7.40M | 11.40M |
| Net profit | 19.50M | 8.00M | -21.40M | -48.10M | 6.40M | 32.70M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.09 | 0.04 | -0.10 | -0.21 | 0.03 | 0.13 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 916.80M | 913.60M | 1.11B | 1.01B | 945.00M | 876.50M | 885.20M | 1.26B |
| Cash & ST investments | 523.00M | 540.50M | 699.40M | 561.30M | 521.10M | 491.20M | 425.30M | 649.80M |
| Inventory | 102.70M | 83.30M | 94.90M | 110.10M | 116.10M | 96.50M | 117.90M | 155.30M |
| Total assets | 1.82B | 1.78B | 1.96B | 1.83B | 1.85B | 1.74B | 1.99B | 2.71B |
| Total current liabilities | 284.00M | 232.80M | 747.40M | 369.30M | 343.50M | 247.10M | 589.70M | 680.50M |
| Short-term debt | -- | 14.50M | 468.20M | 78.50M | 106.30M | 9.80M | 256.40M | 256.60M |
| Long-term debt | 578.80M | 600.90M | 224.10M | 616.50M | 629.50M | 636.00M | 396.30M | 397.10M |
| Total liabilities | 1,089,300,000.00 | 1,064,900,000.00 | 1,197,500,000.00 | 1,156,200,000.00 | 1,159,700,000.00 | 1,054,700,000.00 | 1,213,600,000.00 | 1,257,100,000.00 |
| Total equity | 725.80M | 711.40M | 763.90M | 671.70M | 690.80M | 681.60M | 780.20M | 1.45B |
| Retained earnings | -69.38B | -69.40B | -69.32B | -69.54B | -69.60B | -69.65B | -69.63B | -69.69B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 835.40M | 885.20M | 990.30M | 1.28B | 1.05B | 1.26B |
| Cash & ST investments | 396.80M | 425.30M | 545.60M | 767.40M | 500.80M | 649.80M |
| Inventory | 116.20M | 117.90M | 124.50M | 141.00M | 147.90M | 155.30M |
| Total assets | 1.93B | 1.99B | 2.08B | 2.78B | 2.53B | 2.71B |
| Total current liabilities | 544.70M | 589.70M | 497.50M | 489.60M | 652.50M | 680.50M |
| Short-term debt | 254.70M | 256.40M | 161.20M | 65.00M | 256.00M | 256.60M |
| Long-term debt | 396.10M | 396.30M | 640.50M | 1.22B | 836.30M | 397.10M |
| Total liabilities | 1,204,400,000.00 | 1,213,600,000.00 | 1,358,200,000.00 | 1,943,500,000.00 | 1,681,300,000.00 | 1,257,100,000.00 |
| Total equity | 728.80M | 780.20M | 723.90M | 834.30M | 846.50M | 1.45B |
| Retained earnings | -69.64B | -69.63B | -69.68B | -69.73B | -69.72B | -69.69B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 138.80M | 135.60M | 243.30M | 178.10M | 114.10M | 116.40M | 89.80M | 113.90M |
| Depreciation & amortization | 112.20M | 107.80M | 102.30M | 75.40M | 69.50M | 58.70M | 62.70M | 108.30M |
| Free cash flow | 93.80M | 103.70M | 191.20M | 105.60M | 63.00M | 96.90M | 62.00M | 82.80M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -11.20M | -44.40M | -42.20M | -235.90M | -83.90M | -20.00M | -16.40M | 545.00M |
| Ending cash balance | 530.40M | 547.40M | 708.40M | 572.80M | 515.60M | 481.80M | 432.10M | 659.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 7.80M | 23.80M | 31.00M | 42.50M | -26.30M | 66.70M |
| Depreciation & amortization | 16.60M | 17.90M | 18.20M | 28.80M | 30.70M | 30.60M |
| Free cash flow | 1.00M | 18.30M | 22.50M | 36.90M | -32.20M | 55.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -30.00M | 0 | 0 | 575.00M |
| Ending cash balance | 382.70M | 432.10M | 552.10M | 776.10M | 511.30M | 659.80M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 0.75 | 3.99 | 6.20 | 2.14 | 3.74 | -3.76 | 4.76 | -2.73 |
| ROA %i | 0.28 | 1.60 | 2.47 | 0.82 | 1.39 | -1.44 | 1.87 | -1.29 |
| ROIC %i | 1.86 | 3.54 | 4.89 | 1.93 | 2.51 | -1.32 | 3.35 | -0.75 |
| 5-year avg ROE %i | -0.54 | 2.36 | 6.41 | 2.50 | 4.52 | 3.62 | 3.21 | 0.84 |
| EBIT margin %i | 6.51 | 11.24 | 12.14 | 6.62 | 7.71 | 3.99 | 6.11 | 3.94 |
| FCF / sales %i | 8.30 | 9.13 | 15.95 | 8.17 | 5.70 | 9.69 | 5.72 | 5.45 |
| Current ratioi | 3.23 | 3.92 | 1.49 | 2.72 | 2.75 | 3.55 | 1.50 | 1.85 |
| Quick ratioi | 2.75 | 3.43 | 1.30 | 2.29 | 2.29 | 2.98 | 1.22 | 1.51 |
| Debt / assetsi | 33.29 | 37.14 | 37.69 | 40.73 | 42.20 | 39.58 | 34.72 | 25.81 |
| LT debt / equityi | 83.26 | 90.69 | 35.48 | 99.15 | 97.67 | 99.38 | 55.87 | 30.49 |
| Interest coveragei | 2.15 | 3.79 | 4.03 | 4.18 | 3.47 | 1.41 | 2.40 | 1.37 |
| Revenue CAGR (3Y) %i | 7.64 | 12.18 | 11.04 | 4.57 | -0.89 | -5.86 | -5.68 | 11.14 |
| Net income CAGR (3Y) %i | -- | -32.62 | -- | 42.12 | -19.56 | -- | 30.94 | -- |
| FCF CAGR (3Y) %i | 48.23 | 23.02 | 101.13 | 4.03 | -15.31 | -20.27 | -16.26 | 9.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 0.71 | 4.76 | 2.13 | -5.54 | -7.00 | -2.73 |
| ROA %i | 0.28 | 1.87 | 0.80 | -1.87 | -2.47 | -1.29 |
| ROIC %i | 1.28 | 3.35 | 1.84 | -1.39 | -2.36 | -0.75 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.50 | 6.11 | 4.93 | 0.51 | 1.71 | 3.94 |
| FCF / sales %i | 6.32 | 5.72 | 6.84 | 6.33 | 3.33 | 5.45 |
| Current ratioi | 1.53 | 1.50 | 1.99 | 2.61 | 1.61 | 1.85 |
| Quick ratioi | 1.24 | 1.22 | 1.65 | 2.22 | 1.30 | 1.51 |
| Debt / assetsi | 35.76 | 34.72 | 40.66 | 47.87 | 44.96 | 25.81 |
| LT debt / equityi | 59.91 | 55.87 | 94.68 | 151.60 | 104.02 | 30.49 |
| Interest coveragei | 1.71 | 2.40 | 2.06 | 0.18 | 0.57 | 1.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Network and Service Enablement is the largest reported line at 77.91% of revenue, across 2 reported segments.
- The next-largest line, Optical Security and Performance Products, is a distant second at 22.09% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Network and Service Enablement77.91%
Optical Security and Performance Products22.09%
Region
United States38.06%
EMEA24.07%
Greater China17.05%
Other Asia-Pacific13.90%
Other Americas6.92%
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.